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We performed a genome-scale chromatin immunoprecipitation (ChIP)-chip comparison of two modifications
(trimethylation of lysine 9 [H3me3K9] and trimethylation of lysine 27 [H3me3K27]) of histone H3 in Ntera2 testicular
carcinoma cells and in three different anatomical sources of primary human fibroblasts. We found that in each of the
cell types the two modifications were differentially enriched at the promoters of the two largest classes of transcription
factors. Specifically, zinc finger (ZNF) genes were bound by H3me3K9 and homeobox genes were bound by H3me3K27.
We have previously shown that the Polycomb repressive complex 2 is responsible for mediating trimethylation of
lysine 27 of histone H3 in human cancer cells. In contrast, there is little overlap between H3me3K9 targets and
components of the Polycomb repressive complex 2, suggesting that a different histone methyltransferase is
responsible for the H3me3K9 modification. Previous studies have shown that SETDB1 can trimethylate H3 on lysine 9,
using in vitro or artificial tethering assays. SETDB1 is thought to be recruited to chromatin by complexes containing the
KAP1 corepressor. To determine if a KAP1-containing complex mediates trimethylation of the identified H3me3K9
targets, we performed ChIP-chip assays and identified KAP1 target genes using human 5-kb promoter arrays. We
found that a large number of genes of ZNF transcription factors were bound by both KAP1 and H3me3K9 in normal and
cancer cells. To expand our studies of KAP1, we next performed a complete genomic analysis of KAP1 binding using a
38-array tiling set, identifying ;7,000 KAP1 binding sites. The identified KAP1 targets were highly enriched for C2H2
ZNFs, especially those containing Kru ¨ppel-associated box (KRAB) domains. Interestingly, although most KAP1 binding
sites were within core promoter regions, the binding sites near ZNF genes were greatly enriched within transcribed
regions of the target genes. Because KAP1 is recruited to the DNA via interaction with KRAB-ZNF proteins, we suggest
that expression of KRAB-ZNF genes may be controlled via an auto-regulatory mechanism involving KAP1.
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Introduction
Certain modiﬁcations of the core histones have been
associated with either active or inactive gene expression.
For example, acetylation of histone H3 on lysines 9 and 14 is
associated with regions of the chromatin that are undergoing
transcription in that particular cell type [1–4]. Although
histone H3 methylation can be associated with active
chromatin (e.g., methylation of lysines 4, 36, and 79),
methylation of lysines 9 or 27 (H3me3K9 or H3me3K27,
respectively) is often found in regions of silenced chromatin
[5–11]. Histone acetylation is a dynamic mark, being
controlled by the counteracting effects of histone acetyl-
transferases and deacetylases, providing a means of rapidly
altering transcription of a particular gene in response to
changes in environmental signals or position in the cell cycle
[12]. In contrast, histone methylation is generally believed to
be a more stable mark, suggesting that this modiﬁcation may
be more useful for conferring long-term gene repression,
such as that needed for the permanent repression of tissue-
speciﬁc genes in differentiated tissues. However, recent
studies have indicated that members of the Jumonji protein
family can demethylate lysine 9 [13–16]. These studies have, in
general, examined the effect of Jumonji proteins on global
levels of H3me3K9 (e.g., using western blots and/or by
ﬂuorescent microscopy) or on H3me3K9 at repetitive
elements [15], rather than the H3me3K9 bound to individual
genes. Therefore, the role of the Jumonji proteins in gene
regulation is still unclear. To date, no histone demethylases
that target H3me3K27 have been reported.
The technique of chromatin immunoprecipitation (ChIP)
has been used to demonstrate the presence of H3me3K9 or
H3me3K27 at speciﬁc human loci [17–20]. Promoter regions
bound by H3me3K27 have been identiﬁed in both normal
and cancer cells [8,21,22]. In general, genes whose promoters
are bound by H3me3K27 are expressed at very low levels. In
contrast, few studies have shown localization of H3me3K9 to
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repetitive elements [6], leading to the hypothesis that it is
involved in repression. However, one study did show that an
unspeciﬁed form of histone H3 methylated K9 is associated
with RB1-mediated repression of a mammalian promoter
[23] and other studies have shown association of binding of
H3me3K9 with transcriptional repression of a promoter
region after artiﬁcially tethering of a factor that can recruit
a histone methytransferase [24,25]. Perhaps the best exam-
ples for association of transcriptional repression of an
endogenous gene with the presence of H3me3K9 comes
from an analysis of the POU5F1 promoter during differ-
entiation [20] and of ASCL2 after knockdown of a Jumonji
family member [13]. In contrast, others have found that
H3me3K9 associates with promoters that are bound by the
RNA polymerase II complex [8] or with actively transcribed
genes [17,19,26]. For example, one study found high levels of
H3me3K9 over the highly transcribed gamma globin locus
[26] and a second study found that H3me3K9 was localized
to the coding region of several active genes [17]. Clearly, a
comprehensive comparison of H3me3K9 and H3me3K27
binding sites in human cells is needed to provide insight into
the relative roles of these two modiﬁcations in gene
expression.
We have now compared the binding patterns of H3me3K9
and H3me3K27 at ;26,000 human promoters in four
different cell populations, identifying thousands of pro-
moters bound by each type of modiﬁed histone. Our studies
indicate that the two marks segregate differentially with the
two most common types of transcriptional regulators. We
have also shown that many of the promoters bound by
H3me3K9 are also bound by the corepressor KAP1 (also
known as TIF1B or TRIM28). Finally, we present a genome-
wide screen and characterization of KAP1 target genes in
Ntera2 cells. Our results suggest that Kru ¨ppel-associated box
(KRAB)-zinc ﬁnger (ZNF) transcription factors participate in
an autoregulatory loop involving the KAP1 protein and
trimethylation of histone H3 on lysine 9.
Results
H3me3K9 and H3me3K27 Modifications Are Used to
Silence Different Sets of Transcription Factor Genes
We used ChIP-chip assays with high-density oligonucleo-
tide arrays to analyze the binding patterns of H3me3K9 and
H3me3K27 through 5 kb of 26,000 human promoters (see
Table S1 for a list of all arrays used in this study). We began by
using an antibody that speciﬁcally recognizes histone H3 only
when it is trimethylated on lysine 9 and an antibody that
recognizes histone H3 only when it is trimethylated on lysine
27. We performed ChIP-chip assays using Ntera2 cells and
obtained ranked lists using the Maxfour program, which
ranks each promoter region based on the average of the
intensities of the four consecutive probes (of the 50 that
represent each promoter) that have the highest enrichment
values (Bieda et al., manuscript in preparation). We found
that the sets of target genes that are bound by H3me3K9 and
H3me3K27 are essentially mutually exclusive (Figure 1A). To
determine which speciﬁc types of target genes were selec-
tively silenced by the different histone modiﬁcations, we
compared the promoters that were in the list of top 2,000
H3me3K9 targets and the promoters that were in the list of
top 2,000 H3me3K27 targets using the program DAVID
(http://david.abcc.ncifcrf.gov). This program allows a func-
tional classiﬁcation of a set of genes based on Gene Ontology
descriptions. In addition to classifying genes into different
sets, the program provides a p-value that indicates the
probability that the set of genes was identiﬁed by chance
based on the number of genes in the genome that fall into
that particular category. We found that although the sets of
promoters bound by H3me3K9 and H3me3K27 were differ-
ent, both histone modiﬁcations were speciﬁcally enriched at
the promoters of genes involved in transcription (Table 1; see
also Table S2 for a more detailed list of the signiﬁcantly
enriched gene categories). Interestingly, the two histone
modiﬁcations targeted two distinctly different classes of
transcription factor genes. Similar to previous studies
[8,21,27], the set of developmentally related homeobox
transcription factors were the most highly enriched class of
transcription factor genes bound by H3me3K27 (Figure 1B).
In contrast, homeobox genes were not bound by H3me3K9.
Instead, H3me3K9 bound speciﬁcally to ZNF transcription
factors. Examples of enrichment of H3me3K27 at a homeo-
box gene cluster and of H3me3K9 at a ZNF gene cluster can
be seen in Figure 2. To determine if the selective binding of
H3me3K27 and H3me3K9 to the promoters of different
families of transcription is commonly observed, we per-
formed ChIP-chip experiments using antibodies to H3me3K9
and H3me3K27 with primary cultures of normal fetal lung
ﬁbroblasts, adult foot ﬁbroblasts, and newborn foreskin
ﬁbroblasts. As shown in Figure 1, analysis of 26,000 promoters
revealed that ZNF genes were enriched in the H3me3K9
targets while homeobox genes were enriched in the
H3me3K27 targets in all four cell lines (see also Table S2
for a list of the signiﬁcantly enriched gene categories for the
ﬁbroblast studies).
The KAP1 Corepressor Colocalizes with H3me3K9
We have previously reported that components of the
Polycomb repressive complex 2 colocalize with H3me3K27 in
F9 cells and mouse embryonic stem cells [8]. However, due to
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Identification of KAP1 Binding Sites
Author Summary
Methylation of lysines 9 or 27 of histone H3 (H3me3K9 or
H3me3K27, respectively) has been associated with silenced chro-
matin. However, a comprehensive comparison of the regions of the
genome bound by these two types of modified histone H3 has not
been performed. Therefore, we compared the binding patterns of
H3me3K9 and H3me3K27 at ;26,000 human promoters in four
different cell populations. Our studies indicated that the two marks
segregate differentially with the two most common types of
transcriptional regulators; H3me3K27 is highly enriched at homeo-
box genes and H3me3K9 is highly enriched at zinc-finger genes
(ZNFs). We showed that many of the promoters bound by H3me3K9
are also bound by the corepressor KAP1. A genome-wide screen for
KAP1 target genes revealed a difference in the location of KAP1
binding sites in the ZNF genes versus other targets. In general, KAP1
binding sites were localized to core promoter regions. However,
KAP1 binding sites associated with ZNF genes are near the 39 end of
the coding region. Our results suggest that the KRAB-ZNF family
members participate in an autoregulatory loop involving binding of
the KAP1 protein to the 39 end of the ZNF target genes, resulting in
trimethylation of H3K9 and transcriptional repression.the fact that H3me3K9 and H3me3K27 are bound to different
sets of genes, it is likely that a different repression complex is
responsible for the H3me3K9 modiﬁcations. Several different
proteins can methylate histone H3 on lysine 9 [28,29]. A
hallmark of such proteins is the presence of a 130-aa Su(var),
Enhancer of zeste, Trithorax (SET) domain. There are
numerous proteins encoded in the human genome that
contain SET domains, several of which (e.g., G9a, SUV39H1/2,
EHMT1, and SETDB1) have been recently characterized as
functional histone methyltransferases. The different bio-
logical roles played by the different histone methylases is
not yet clear. However, SUV39H1/2 is thought to be
responsible for methylation in pericentric heterochromatin,
whereas G9a may be involved in methylation in euchromatin
regions [28,30]. None of the histone methyltransferases
contain DNA binding motifs and thus must be brought to
the chromatin via interaction with other proteins. It has been
proposed that complexes that mediate methylation of
H3me3K9 may be recruited to promoters via E2F family
members. For example, SUV39H1 may be recruited to
promoters by RB1 [31] and EHMT1 may be recruited to
promoters by E2F6 [32]. A recent study has suggested that
EHMT2 can be recruited to the DNA via interaction with an
orphan nuclear receptor called NR0B2 [33]. SETDB1, another
protein that has a SET homology domain [34], may be
responsible for the H3K9 methylation that is maintained in
Table 1. H3me3K9 and H3me3K27 Predominantly Target Tran-
scription Factors in Four Different Cell Types
Cell Type p-Value for Transcription
H3me3K9 H3me3K27
Ntera 1E70 7E78
Foot 1E44 1E48
Lung 2E54 1E47
Foreskin 1E22 9E34
The top 2,000 gene promoters bound by either H3me3K9 or H3me3K27 were identified
from 5-kb promoter arrays using the Maxfour peakcalling program (see Materials and
Methods). Functional categories were determined using the program DAVID in Ntera2
cells and for foot, lung, and foreskin fibroblasts. p-Values for the significance of
enrichment are shown for the predominantly represented category ‘‘transcription.’’
doi:10.1371/journal.pgen.0030089.t001
Figure 2. H3me3K9 binds to ZNF Gene Clusters and H3me3K27 Binds to
Homeobox Gene Clusters
Binding patterns of H3me3K9 and H3me3K27 (from 5-kb promoter array
ChIP-chip data) in Ntera2 cells are compared at a ZNF gene cluster (1.6
Mb of Chromosome 19, top panel) and at the HoxC cluster (0.15 Mb of
Chromosome 12, bottom panel).
doi:10.1371/journal.pgen.0030089.g002
Figure 1. H3me3K9 and H3me3K27 Target Different Classes of
Transcription Factors
(A) The Maxfour values from the 5-kb promoter array set (see Materials
and Methods) are plotted for Ntera2 ChIP-chip data of H3me3K27 (x-axis)
and H3me3K9 (y-axis).
(B) Functional categories for the top 2,000 genes bound by either
H3me3K9 or H3me3K27 were determined using the program DAVID in
Ntera2 cells (black bars), foot fibroblasts (white bars), lung fibroblasts
(hatched bars), and foreskin fibroblasts (gray bars). The category
‘‘transcription’’ was significantly enriched for both H3me3K9 and
H3me3K27 (see Table 1 and Table S2). p-Values for the significance of
enrichment for zinc fingers and homeoboxes, two major classes of
transcription factors, are shown.
doi:10.1371/journal.pgen.0030089.g001
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Identification of KAP1 Binding Sitesthe SUV39H1/2 double knockout mouse [35]. It is thought
that SETDB1 is brought to the DNA in a complex with a
corepressor called KAP1 [34,36]. For example, artiﬁcially
tethering KAP1 to chromatin can result in gene silencing,
methylation of lysine 9, and recruitment of SETDB1 [24]. This
suggests that KAP1 may play a role in performing the
methylation of lysine 9 of H3. However, most studies of KAP1
have used artiﬁcial genomic tethers (such as Gal4KAp1 fusion
proteins) due to the fact that KAP1 target genes have not
been identiﬁed. Therefore, to address the possibility that
KAP1 might colocalize with H3me3K9 marks, we ﬁrst needed
to identify KAP1 target genes.
We began by choosing two different antibodies to KAP1,
one rabbit polyclonal and one mouse monoclonal antibody.
We reasoned that if the same sites were identiﬁed using two
different antibodies, then we would have conﬁdence that the
KAP1 ChIP experiments were identifying true binding sites.
Because we did not know if KAP1 prefers to bind to promoter
regions or to regions distant from core promoters, we ﬁrst
applied the amplicons made from the KAP1 ChIP samples to
ENCODE arrays (which represent approximately 1% of the
human genome, including ;400 genes; see http://www.
genome.gov/10005107). We identiﬁed two sites at the highest
stringency level of the Tamalpais Peaks program [37] that
were bound by KAP1 using both the monoclonal and
polyclonal KAP1 antibodies (Figure 3). Peak identiﬁcation
Figure 3. Identification of KAP1 Binding Sites Using ENCODE Tiling Arrays
(A) ChIP-chip analysis in Ntera2 cells using two antibodies (rabbit polyclonal, r-KAP1 and mouse monoclonal, m-KAP1) raised against different KAP1
epitopes. Two KAP1 binding sites (one in Enm005, top panel and one in Enr132, bottom panel) were identified using the Tamalpais peak-calling
program [37].
(B) PCR analysis of the two identified KAP1 binding sites in ENCODE regions ENm005 and ENr132 was performed using a third biological replicate of
amplicons using the rabbit KAP1 antibody. The enrichment of KAP1 and H3me3K9 is shown in comparison to total chromatin DNA. IgG amplicons were
analyzed as a negative control.
doi:10.1371/journal.pgen.0030089.g003
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Identification of KAP1 Binding Sitesrequired that at least six oligomer probes in a row (spanning
238 bp) have an enrichment value in the top 2% of all probes
on the array (providing a p-value of p , 0.0001). The two
identiﬁed KAP1 binding sites are located within the tran-
scribed region of IFNAR2 in ENCODE region ENm005 and
within the transcribed region of ATP11A in ENCODE region
ENr132. To conﬁrm the ChIP-chip results, we prepared a new
set of KAP1 amplicons, as well as H3me3K9 amplicons, and
performed PCR analysis using primers speciﬁc to the two
KAP1 binding sites. As seen in Figure 3B, not only did we
conﬁrm binding of KAP1 to these sites, but we also
demonstrated that the same sites were bound by H3me3K9.
With conﬁdence that our KAP1 ChIP-chip assays could
identify true KAP1 binding sites, we next performed
duplicate ChIP experiments using two independent sets of
Ntera2 cells and antibodies to KAP1, SUZ12, H3me3K9, and
H3me3K27, prepared amplicons, and performed ChIP-chip
experiments using a two-array set of ;26,000 human
promoters. As described above, target promoters were
identiﬁed with the Maxfour peak-calling program. A list of
high conﬁdence target genes was generated by selecting the
top ranked 2,000 promoters that were bound in the two
independent experiments for each antibody. We then
determined how many of the SUZ12 or KAP1 targets were
also co-occupied by H3me3K9 and H3me3K27. This led to a
conservative, but high conﬁdence set of co-occupied targets,
since each target had to be identiﬁed in four out of four
arrays. In support of the hypothesis that the modiﬁcation of
H3me3K9 must be accomplished by a complex other than
Polycomb repressive complex 2, we saw no signiﬁcant overlap
between SUZ12 targets and H3me3K9 targets (Figure 4A).
However, as expected, we found that many promoters were
bound by both SUZ12 and H3me3K27.
We next compared the top 2,000 KAP1 targets to the top
2,000 H3me3K9 or top 2,000 H3me3K27 targets. We found
that a fourth of KAP1 targets also carried the histone
modiﬁcation H3me3K9 but only 11% of KAP1 targets were
bound by H3me3K27 (Figure 4B). To determine if the
promoters that were bound by both KAP1 and H3me3K9
represented a distinct class of genes, we again used the
DAVID analysis program. Interestingly, the promoters bound
by both KAP1 and H3me3K9 in Ntera2 cells were highly
enriched for ZNF transcription factor genes (p-value 5E27).
Similarly, ChIP-chip experiments using antibodies to KAP1
and H3me3K9 in primary cultures of foot ﬁbroblasts also
revealed that the target genes occupied by both KAP1 and
H3me3K9 were highly enriched for ZNF transcription factors
(p-value 2E32).
The signiﬁcant overlap between KAP1 and H3me3K9
suggests that KAP1 may indeed be functioning as a
corepressor in a complex that mediates methylation of lysine
9 of H3. To test this hypothesis, we examined the expression
level of different classes of KAP1 and H3me3K9 target genes.
To do so, we used NimbleGen expression arrays to analyze
RNA levels of the KAP1 target genes in Ntera2 cells, using an
average of data obtained from expression arrays probed with
RNA isolated from two different cultures of Ntera2 cells. For
comparison, we have also analyzed the expression levels of
the top 20% of all RNAs on the NimbleGen array. Of the top
2,000 KAP1 and top 2,000 H3me3K9 target genes, 1,952 and
1,842, respectively, were represented on the NimbleGen
expression array. As can been seen in Figure 5, the genes
whose promoters are bound by KAP1 and/or H3me3K9 are, in
general, expressed at low levels. The repression of targets
bound by KAP1 and H3me3K9 is particularly evident in the
subcategory of ZNF target genes or KRAB-ZNF target genes.
Identification of KAP1 Targets on a Genome-Wide Scale
Previous studies of human transcription factors have
indicated that although some transcription complexes are
often bound near core promoter regions [37], many tran-
scription complexes bind throughout the genome, with
perhaps 20%–30% of the detected sites near core promoters
[38,39]. In particular, we noted that the two KAP1 binding
sites identiﬁed using ENCODE arrays were located within
transcribed regions and not at core promoters. Thus, it is
Figure 4. KAP1 and H3me3K9 Bind to a Common Set of Promoters in Ntera2 Cells
Chart showing the percentage of (A) SUZ12 target promoters and (B) KAP1 target promoters that are also bound by H3me3K9 or H3me3K27. For each
factor, the top 2,000 target promoters (5-kb array set) from two biological replicate ChIP-chip assays were used. This results in high confidence setso f
genes co-occupied by H3me3K9 or H3me3K27 since the target genes had to be present in all four arrays analyzed.
doi:10.1371/journal.pgen.0030089.g004
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Identification of KAP1 Binding Siteslikely that promoter arrays would not identify a complete list
of genes regulated by KAP1. Therefore, we performed a
genome-wide ChIP-chip experiment using KAP1 ChIP sam-
ples from Ntera2 cells and a set of 38 arrays, which were
composed of 50mers spaced about 100 nt apart that
represented the entire nonrepetitive portion of the human
genome (see Table S3 for the genomic coordinates on each
array). We used the Tamalpais peak-calling program ([37]; see
also http://chipanalysis.genomecenter.ucdavis.edu/cgi-bin/
tamalpais.cgi) and identiﬁed sites that represented regions
spanning at least four probes in a row that were in the top 2%
of all probes on the array. Using these criteria, we identiﬁed
;7,000 KAP1 binding sites in the human genome (see Table
S4). A comparison of the number of binding sites identiﬁed
on each chromosome using promoter arrays and the genome
tiling arrays is shown in Table 2.
Inspection of the chromosomal location of the KAP1
binding sites indicated that, in general, the larger chromo-
somes contained more KAP1 targets than did the smaller
chromosomes. However, there were several cases in which
large clusters of KAP1 targets resulted in a higher-than-
expected number of targets on a particular chromosome. For
example, Chromosomes 7 and 19 were highly enriched for
KAP1 targets using the whole-genome arrays (Table 2).
Interestingly, Chromosome 19 contains clusters of ZNF
transcription factor genes, with 266 of the approximately
800 total human ZNF genes located mainly within 11 large
familial clusters [40]. The clustered binding pattern of KAP1
targets on Chromosome 19 can be seen in Figure 6A. To
determine if the KAP1 targets that were identiﬁed using the
whole-genome array were similar to those identiﬁed using the
promoter arrays, we analyzed the set of ;7,000 KAP1 binding
sites using the DAVID program. As expected from the large
number of KAP1 binding sites on Chromosomes 19 and 7, the
Gene Ontology analysis indicated that a large number of the
genome-wide KAP1 targets are ZNF transcription factors
(Figure 7). Thus, both the promoter arrays and the whole-
genome arrays identiﬁed ZNF genes as KAP1 targets. The
high number of targets on Chromosomes 19 and 7 is not due
to large-scale spreading throughout a region, as we have
previously shown for SUZ12 and H3me3K27 [8]. Although
there are many binding sites on each of these chromosomes,
the average KAP1 binding site spans only 820 bp (Table S4).
PCR analysis using a new biological replicate of KAP1
amplicons conﬁrmed binding of KAP1 and H3me3K9 to
ZNF genes (Figure 6B). Four of the binding sites analyzed are
located within the transcribed region of ZNF genes on
Chromosome 19 (ZNF554, ZNF426, ZNF333, and ZNF433)
and two binding sites are located in distal regions on
Chromosome 7 (.100kb from the transcription start sites
(TSSs) of ZNF genes ZNF479 and ZNF679).
Having identiﬁed a large set of KAP1 targets in a
completely unbiased manner, we could now determine the
preferred binding location for KAP1. The distance of KAP1
binding sites to the nearest transcription start site was
determined using knownGenes from the University of
California Santa Cruz genome browser (http://genome.ucsc.
Figure 5. KRAB-ZNF Genes Bound by KAP1 Are Expressed at Low Levels
Box plot showing 25th, 50th, and 75th quartile expression levels for the
most highly expressed RNAs (the top 20% of all RNAs on the array) and
for different target gene categories: all KAP1 target genes, all H3me3K9
target genes, genes co-occupied by KAP1 and H3me3K9, ZNF genes co-
occupied by KAP1 and H3me3K9, and KRAB-ZNF genes co-occupied by
KAP1 and H3me3K9. Whiskers show the 2.5th and 97.5th percentiles. For
these analyses, average RNA expression values from two independent
experiments were used.
doi:10.1371/journal.pgen.0030089.g005
Table 2. KAP1 Targets Listed by Chromosome in Ntera2 Cells
Chromosome 5-kb Promoter Array Whole-Genome Array
1 274 619
2 118 555
3 128 431
46 8 1 6 2
57 5 2 0 6
67 8 3 1 3
79 5 7 5 6
85 7 3 7 5
99 3 1 4 9
10 75 410
11 98 352
12 99 497
13 36 262
14 81 306
15 63 239
16 68 127
17 107 89
18 26 16
19 142 380
20 49 100
21 26 94
22 44 77
X9 1 3 0 6
Y1 1 1 1 9
The number of the top 2,000 KAP1 target promoters from 5-kb promoter arrays of two
biological replicates and the number of the ;7,000 KAP1 targets from whole-genome
tiling arrays are listed according to their chromosomal location (see Materials and
Methods for peak calling).
doi:10.1371/journal.pgen.0030089.t002
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Identification of KAP1 Binding Sitesedu). Although we did note that 24% of the KAP1 binding
sites were located more than 50 kb upstream or downstream
of transcription start sites of known genes, these were not
considered in our location analysis; it is possible that many of
these KAP1 target sites that appear to be extremely far from
transcription start sites are, in fact, near to start sites of as-yet
undiscovered genes or transcripts. As shown in Figure 8A, we
performed the location analysis within 50 kb upstream or
downstream of a known gene for two categories of KAP1
target genes, ZNF target genes and non-ZNF target genes. We
found that for the majority of non-ZNF target genes the
KAP1 binding site is located in the core promoter region
(deﬁned as 5 kb upstream or downstream of the start site of
transcription). The remaining binding sites are distributed
fairly evenly in the regions between 5 kb and 50 kb upstream
or downstream of the start sites. In contrast, the location
analysis was distinctly different for the subset of ZNF genes
that are KAP1 target genes. It was very striking that many of
the KAP1 binding sites associated with ZNF genes are
downstream of the start site (Figure 8A). A more detailed
analysis of the KAP1 sites that are located downstream of the
start sites of ZNF genes revealed that 74% were located
within the transcribed regions. Interestingly, the majority of
these KAP1 binding sites were found towards the 39 end of
the ZNF gene (Figure 8B).
Discussion
We have shown that the genes for the two largest classes
of site-speciﬁc DNA binding transcription factors are bound
by distinct histone modiﬁcations; trimethylation of histone
H3 on lysine 27 is highly enriched at genes encoding
homeobox transcription factors (the second largest family of
Figure 6. Identification of KAP1 Targets in Ntera2 cells Using Whole-Genome Tiling Arrays
(A). The KAP1 binding patterns along Chromosome 19 (and a 200-kb subregion) containing clusters of ZNF genes are shown. Chromosome positions
(Mb) are indicated on the x-axis. The black bar indicates transcribed region of ZNF433 and grey bars represent other transcribed regions (ZNF-like
transcripts).
(B) PCR analysis of six KAP1 binding sites was performed using a separate biological replicate of KAP1 amplicons. Four KAP1 binding sites are located
within the transcribed region of ZNF genes on Chromosome 19 (ZNF554, ZNF426, ZNF333, and ZNF433) and two KAP1 binding sites are located
.100kb from TSS of ZNF genes on Chromosome 7 (ZNF479 and ZNF679). An intergenic region of Chromosome 8 was used as a control for absence of
KAP1 binding. The enrichment of KAP1 and H3me3K9 is shown in comparison to total chromatin DNA; IgG amplicons were analyzed as a negative
control.
doi:10.1371/journal.pgen.0030089.g006
Figure 7. Functional Annotation of Genome-Wide KAP1 Targets
Functional categories for KAP1 target genes were determined using the
program DAVID after elimination of genes that had no annotation and
genes encoding hypothetical proteins. The top ten categories based on
their p-value are shown. Ontology terms are shown on the y-axis; p-
values for the significance of enrichment are graphed along the x-axis.
doi:10.1371/journal.pgen.0030089.g007
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Identification of KAP1 Binding Siteshuman transcription factors) and trimethyation of histone
H3 on lysine 9 is highly enriched at genes encoding ZNF
transcription factors (the largest family of human tran-
scription factors). The Kru ¨ppel-type ZNF domain is the
most common DNA binding domain in the human genome
[41] and at least one third of the ZNF genes include the
KRAB domain, which is thought to recruit histone modify-
ing proteins via interaction with the corepressor KAP1
[36,42,43]. The ability of the KRAB-ZNF proteins to interact
with KAP1 has led to previous models of KAP1-mediated
repression being targeted to the genome by ZNF proteins. In
vitro biochemical and cellular artiﬁcial tethering experi-
ments have suggested that the corepressor KAP1 might
recruit a histone methylase to promoters, resulting in lysine
9 methylation. However, testing this model has not been
possible due to the fact that no known targets of KAP1 had
been identiﬁed. We have now identiﬁed thousands of KAP1
binding sites, using both promoter and genomic tiling
arrays, and have shown that many of the KAP1 binding sites
are also enriched for H3me3K9.
Autoregulation of KRAB-ZNF Gene Family Expression
Unexpectedly, we have shown that the major targets of
KAP1-mediated repression are ZNF genes themselves. For
example, in Ntera2 cells KAP1 binds to 60% (212 of 355) of all
KRAB-ZNF genes in the genome. This suggests that KAP1
represses transcription of many KRAB-ZNF genes due to its
recruitment to their transcribed regions by interaction with
Figure 8. Location Analysis of Genome-Wide KAP1 Targets
(A) Distribution of the distance between KAP1 binding sites and closest transcription start sites from University of California Santa Cruz KnownGenes
(HG17) is shown. Distances are calculated from the center of the KAP1 binding site to the transcription start site and binned in 5-kb intervals between
50 kb upstream and 50 kb downstream of TSS. KAP1 binding sites within each interval are given as a percentage for ZNF target genes (grey) and for
KAP1 target genes excluding ZNF genes (black).
(B) Analysis of 277 KAP1 binding sites located within the transcribed regions of ZNF genes. Position of KAP1 binding is plotted relative to the length of
the ZNF target gene (59 end at 0%; 39 end at 100%).
doi:10.1371/journal.pgen.0030089.g008
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Identification of KAP1 Binding Sitesthe few KRAB-ZNF proteins that are expressed in a cell
(Figure 9). An analysis of the expression level of the different
KRAB-ZNF proteins in Ntera2 cells conﬁrmed that the
majority of KRAB-ZNF genes—such as the KAP1 target genes
ZNF426, ZNF333, and ZNF554—are not expressed. However,
a few KRAB-ZNF genes are not bound by KAP1 in Ntera2
cells and are highly transcribed, suggesting that they may play
a role in the recruitment of KAP1 to the other KRAB-ZNF
target genes. Thus, our studies support an autoregulatory
model in which KAP1 represses the expression of hundreds of
ZNF genes due to its recruitment to chromatin by a small set
of ZNF proteins that are expressed in a particular cell.
KAP1 Binds to Core Promoters of Most Genes but to 39
Ends of ZNF Genes
As indicated above, we have shown that the most highly
enriched class of target genes for KAP1 is ZNF genes, many
of which encode KRAB-ZNF proteins. Interestingly, we ﬁnd a
difference in the location of KAP1 binding sites in the ZNF
genes versus other targets. In accordance with our identi-
ﬁcation of a large set of KAP1 targets using promoter arrays,
we ﬁnd that thousands of the KAP1 targets identiﬁed on the
whole-genome tiling arrays show localization at the pro-
moter region (deﬁned as 5 kb upstream or downstream of
the start site). In contrast, the KAP1 binding sites associated
with ZNF genes are predominantly localized within tran-
scribed gene regions, near the 39 end of the gene. This
suggests that the recruitment of KAP1 to the ZNF genes and/
or the function of KAP1 in regulating expression of ZNF
genes might be different than for other KAP1 targets. The
other ;200 DNA binding transcription factors that are
KAP1 targets but are not ZNFs show a promoter-localized
KAP1 binding pattern (unpublished data). Thus, the 39 end-
localized KAP1 binding pattern is unique to ZNF tran-
scription factors.
A recent study using DamID, rather than ChIP, found that
37% of CBX1 (HP1-BETA) targets and 48% of the SUV39H1
targets correspond to KRAB-ZNF genes on Chromosome 19
[44]. CBX1 is thought to be able to recognize methylated
lysine 9. In addition, it has been shown that KAP1 interacts
with CBX1 [45] and that this interaction is required for
the KAP1 corepressor activity [24]. Thus, our ﬁnding that
KAP1 plus H3me3K9 binds to KRAB-ZNF genes ﬁts well with
the previous study showing that CBX1 plus SUV39H1 bind
to this same class of genes. However, Vogel et al. [44] found
that CBX1 coats large domains of Chromosome 19, ranging
up to 4 MB, whereas we saw very limited spreading of KAP1.
It is possible that KAP1 binding within the transcribed
region of KRAB-ZNF genes remains localized but recruit-
ment of the methyltransferase results in spreading of the
H3me3K9 mark. It is also possible that differences in
chromatin binding patterns could be due to differences in
the cell types used in the two experiments. Our genomic
tiling arrays were performed using Ntera2 testicular car-
incoma cells whereas the CBX1 study used MCF7 breast
cancer cells.
Future Studies
We have proposed that the general repression of KRAB-
ZNF genes is accomplished by recruitment of the KAP1
corepressor to their transcribed regions via interaction with
one or more of the KRAB-ZNF proteins that is highly
expressed in that particular cell type. It is likely that either
simultaneously with or subsequent to KAP1 recruitment a
histone methyltransferase such as SUV39H1 or SETDB1
associates with KAP1, resulting in trimethylation of histone
H3 at lysine 9. In support of this hypothesis, we have
preliminary evidence that reduction of the levels of KAP1 in
human 293 cells by stable expression of small interfering
RNAs results in a reduction of the levels of H3me3K9 at KAP1
binding sites (Figure S1). Due to the fact that we can identify
KAP1 bound promoters that are not bound by H3meK9, we
suggest that the recruitment of the histone methyltransferase
is a step subsequent to KAP1 binding to the chromatin. This
hypothesis is also supported by the ﬁnding that forced
expression of KAP1 leads to the subsequent trimethylation of
lysine 9 of histone H3 of a chromatinized reporter gene [24].
It is also possible that a histone demethylase is associated with
the promoters that are bound by KAP1 but not H3me3K9
[13,14]; future studies will be focused on this aspect of the
model. In addition, studies are in progress to identify the
speciﬁc KRAB-ZNFs responsible for 39 end localized autor-
egulatory repression of the KRAB-ZNF family in different
types of human cells.
Figure 9. Autoregulation Model for KRAB-ZNFs
Shown is a model illustrating autoregulation of the family of KRAB-ZNFs by KRAB-ZNF-mediated recruitment of KAP1 to the coding regions of other
KRAB-ZNF genes. ZNF426, ZNF333, and ZNF533 are KAP1 targets and are not expressed in Ntera2 cells.
doi:10.1371/journal.pgen.0030089.g009
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Cell culture. Ntera2 and HEK293 cells were grown in Dulbecco’s
Modiﬁed Eagle Medium supplemented with 10% FBS, 2mM gluta-
mine, and 1% penicillin/streptomycin. The stable KAP1 knockdown
cell line K928-cl10 was grown as above, with the addition of 10ug/ml
puromycin [24]. Human ﬁbroblast cultures were propagated in
Dulbecco’s Modiﬁed Eagle Medium supplemented with 10% fetal
bovine serum and 1% penicillin/streptomycin until 80% conﬂuent.
Fibroblasts were then synchronized in G0 by the addition of media
containing only 0.1% fetal bovine serum for 48 h [46]. All cells were
incubated at 37 8C in a humidiﬁed 5% CO2 incubator.
ChIP assays and amplicon preparation. ChIP assays (1 3 10
7 cells/
assay) were performed following the protocol provided at http://
genomics.ucdavis.edu/farnham and http://genomecenter.ucdavis.edu/
expression_analysis. The primary antibodies used in this study were
as follows: rabbit polyclonal KAP1 IgG (ab10483; Abcam, http://www.
abcam.com), mouse monoclonal KAP1 IgG (ab22553; Abcam), two
different rabbit polyclonal H3me3K9 IgGs (ab1186 and ab1186;
Abcam), rabbit polyclonal H3me3K27 IgG (07–449; Upstate/Millipore,
http://www.upstate.com), and rabbit polyclonal SUZ12 IgG (ab12201;
Abcam). The secondary rabbit anti-mouse IgG was purchased from
MP Biomedicals (55436; http://www.mpbio.com). The nonspeciﬁc
rabbit IgG used as a negative control in the ChIP assays was
purchased from Alpha Diagnostic International (20009–5; http://www.
4adi.com). For PCR analysis of the ChIP samples prior to amplicon
generation, QIAquick-puriﬁed (Qiagen, http://www1.qiagen.com) im-
munoprecipitates were dissolved in 50 ll of water. Standard PCR
reactions using 2 ll of the immunoprecipitated DNA were
performed. PCR products were separated by electrophoresis through
1.5% agarose gels and visualized using ethidium bromide. Amplicons
were prepared by adapting the standard protocol for whole-genome
ampliﬁcation using the Sigma GenomePlex WGA kit (http://www.
sigmaaldrich.com) as described in O’Geen et al. [47]. Brieﬂy, the
initial random fragmentation step was eliminated and DNA from an
entire ChIP sample or from 10 ng of total chromatin was ampliﬁed.
This usually provides enough sample for one array hybridization.
However, amplicons for the whole-genome tiling array set (38 arrays)
were prepared from ten pooled ChIP samples. A detailed protocol for
the WGA method is provided at http://genomics.ucdavis.edu/farnham
and http://genomecenter.ucdavis.edu/expression_analysis.
ChIP-chip assays. Amplicons were applied either to ENCODE
arrays, 5-kb promoter arrays or to the human genome tiling array set
consisting of 38 arrays (see http://www.nimblegen.com for details). The
labeling and hybridization of DNA samples for ChIP-chip analysis was
performed by NimbleGen Systems, except that ENCODE arrays were
hybridized at University of California Davis. Brieﬂy, each DNA sample
(1 lg) was denatured in the presence of 59-Cy3- or 59-Cy5-labeled
random nonamers (TriLink Biotechnologies, http://www.
trilinkbiotech.com) and incubated with 100 units (exo-) Klenow
fragment (NEB, http://www.neb.com) and dNTP mix [6 mM each in TE
buffer (10 mM Tris/1 mM EDTA, pH 7.4; Invitrogen, http://www.
invitrogen.com)] for 2 h at 37 8C. Reactions were terminated by
addition of 0.5 M EDTA (pH 8.0), precipitated with isopropanol, and
resuspended in water. Then, 13 lg of the Cy5-labeled ChIP sample and
13 lg of the Cy3-labeled total sample were mixed, dried down, and
resuspended in 40 ll of NimbleGen Hybridization Buffer (NimbleGen
Systems) plus 1.5 lg of human COT1 DNA. After denaturation,
hybridization was carried out in a MAUI Hybridization System
(BioMicro Systems, http://www.biomicro.com) for 18 h at 42 8C. The
arrays were washed using NimbleGen Wash Buffer System (Nimble-
Gen Systems), dried by centrifugation, and scanned at 5-lm resolution
using the GenePix 4000B scanner (Axon Instruments, http://www.
axon.com). Fluorescence intensity raw data were obtained from
scanned images of the oligonucleotide tiling arrays using NIMBLES-
CAN 2.0 extraction software (NimbleGen Systems). For each spot on
the array, log2-ratios of the Cy5-labeled test sample versus the Cy3-
labeled reference sample were calculated. Then, the biweight mean of
this log2 ratio was subtracted from each point; this procedure is
approximately equivalent to mean normalization of each channel.
Data analysis. Sites bound by KAP1 on the ENCODE arrays were
identiﬁed using the highest stringency level (six consecutive probes
above the 98th percentile threshold, p , 0.0001) of the Tamalpais
peak-calling algorithm previously described [37]; see also http://
genomics.ucdavis.edu/farnham. However, the peak-calling algorithm
was adapted slightly to identify KAP1 sites on the whole-genome
tiling arrays (we used four consecutive probes above the 98th
percentile threshold, p , 0.05). This adjustment was made due to
the difference in probe spacing between ENCODE arrays (38 bp) and
the whole-genome arrays (100 bp). A complete list of KAP1 binding
sites identiﬁed on the whole-genome tiling array is provided as Table
S4. The 5-kb promoter array set consists of two individual arrays
(promoter 1 and promoter 2). Two different designs, HG17 and
HG18, were used in this study; the exact design used for each
experiment is indicated in Table S1. The HG17 promoter array set
covers 4.2 kb upstream and 800 bp downstream of the TSS, whereas
the HG18 promoter array set covers 3.5kb upstream and 750 bp
downstream of the TSS. Regions on the 5-kb promoter arrays bound
by the individual factors were determined using the Maxfour peak-
calling method (Bieda et al., in preparation). Brieﬂy, a value was
assigned based on the highest mean of four consecutive probes in
each promoter. Promoters were then ranked by their Maxfour values
for promoter 1 and promoter 2 separately. The list of the top 2,000
targets for a 5-kb promoter array set was then created by combining
the 1,000 highest ranked promoters from promoter array 1 and the
1,000 highest ranked promoters from promoter array 2. The location
analysis of KAP1 binding sites was performed using the knownGene
database available at http://genome.ucsc.edu (HG17; assembly May
2004). Functional annotations were performed using the program
Database for Annotation, Visualization, and Integrated Discovery
(DAVID) 2.1 (http://david.abcc.ncifcrf.gov), as previously described [8].
RNA expression arrays. Total RNA was prepared from 5 3 10
6
Ntera cells using RNAeasy Kit (Qiagen) following the manufacturer’s
instructions. RNA quality was ensured using the Agilent Systems
Bioanalyzer (http://www.agilent.com). The RNA was hybridized to
human whole-genome expression microarrays from NimbleGen,
which contain probes for every human gene based on genome build
HG18 from the University of California Santa Cruz database (more
details at http://www.nimblegen.com). Total RNA (10 lg) was used to
synthesize cDNA using the SuperScript Double-Stranded cDNA
synthesis kit (Invitrogen). The labeling of RNA samples, array
hybridization and preliminary RNA expression analysis (data normal-
ization) was performed by NimbleGen Systems.
Supporting Information
Figure S1. ChIP Analysis in KAP1 Knockdown Cells
Found at doi:10.1371/journal.pgen.0030089.sg001 (1.2 MB PDF).
Table S1. List of ENCODE and Promoter Arrays
Found at doi:10.1371/journal.pgen.0030089.st001 (30 KB XLS).
Table S2. Gene Ontology Analyses of H3me3K9 and H3me3K27
Targets
Found at doi:10.1371/journal.pgen.0030089.st002 (12 KB XLS).
Table S3. List of Whole-Genome Tiling Arrays
Found at doi:10.1371/journal.pgen.0030089.st003 (22 KB XLS).
Table S4. List of ;7,000 KAP1 Binding Sites
Found at doi:10.1371/journal.pgen.0030089.st004 (916 KB XLS).
Accession numbers
The National Center for Biotechnology Information (NCBI) Entrez
(http://www.ncbi.nlm.nih.gov/gquery/gquery.fcgi) accession numbers
for the genes discurssed in this paper are KAP1 (also known as
TRIM28, TIF1B, TF1B, and RNF96), NM_005762 and SUZ12 (also
known as JJAZ1, KIAA0160, and CHET9), NM_015355.
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